Stem cells, regenerative medicine and cellular rehabilitation

  • V. N. Zalessky National Science Center «Institute of Cardiology named after M.D. Strazhesko» of the National Academy of Medical Sciences of Ukraine
Keywords: stem cells, regenerative medicine and cellular rehabilitation

Abstract

Regenerative medicine is a new interdisciplinary field in biomedical science, which aims at the repair or replacement of the defective tissue or organ by congenital defects, aging, injury or diseases. Various cell-related techniques are a hot topic in the current press, and stem cell research can help us to expand our understanding of development as well as the pathogenesis of diseases and open a new area for regenerative medicine. Is now regenerative medicine and rehabilitation problems tightly intertwined. Rehabilitation specialist not only must be aware of cutting edge medical advances but also with physical therapy doctors must work closely with basic scientist (relatively to regenerative medicine problems) to guide the development of clinical relevant protocols. New direction of cellular rehabilitation open steps vertical integration between doctors and scientists of the medico-biological profile in toward.

Downloads

Download data is not yet available.

References

1. Залесский В. Н., Дынник О. Б. Эндотелиоцитоподобные стволовые клетки и их антиишемический потенциал // Кровообіг та гемостаз. – 2004. – № 2/3. – С. 20–26.

2. Корочкин Л. И. Биология индивидуального развития (генетический аспект): Учебник. – М.: Изд-во МГУ, 2002. – 262 с.

3. Ambrosio F., Ferrari R. J., Distefano G. et al. The synergistic effect of treadmill running on stem-cell transplantation to heal injured skeletal muscle // Tissue Eng. Part A. – 2010. – Vol. 16, N 3. – P. 839–849.

4. Ambrosio F., Russell A. Regenerative rehabilitation: a call to action // J. Rehabil. Res. Dev. – 2010. – Vol. 47, N 3. – P. XI–XV.

5. Ambrosio F., Boninger M. L., Brubaker C. E. et al. Guest Editorial: Emergent themes from Second Annual Symposium on Regenerative Rehabilitation, Pittsburgh, Pennsylvania // J. Rehabil. Res. Dev. – 2013. – Vol. 50, N 3. – P. VII–XIV.

6. Atala A., Lauza R., Nerem R., Thomson J. Principles of regenerative medicine. – New York: Academic Press, 2007. – 1472 p.

7. Baetge E. E. Production of beta-cells from human embryonic stem cells // Diabetes Obes. Metab. – 2008. – Vol.10 (Suppl. 4). – P. 186–194.

8. Bambakidis N. C., Theodore N., Nakaji P. et al. Endogenous stem cell proliferation after central nervous system injury: alternative therapeutic options // Neurosurg. Focus. – 2005. – Vol. 19, N 3. – P. E1.

9. Barber J. G., Handorf A. M., Allee T. J., Li W. J. Braided nanofibrous scaffold for tendon and ligament tissue engineering // Tissue Eng. Part A. – 2013. – Vol. 19, N 11/12. – P. 1265–1274.

10. Barnabé-Heider F., Frisén J. Stem cells for spinal cord repair // Cell. Stem. Cell. – 2008. – Vol. 3, N 1. – P. 16–24.

11. Batter A., Leor J. Stem Cell and Gene0Based Therapy: Frontiers Intogenerative Medicine. – Springer, 2006. – 422 p.

12. Blum B., Benvenisty N. The tumorigenicity of human embryonic stem cells // Adv. Cancer Res. – 2008. – Vol. 100. – P. 133–158.

13. Bondesen B. A., Mills S. T., Pavlath G. K. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms // Am. J. Physiol. Cell Physiol. – 2006. – Vol. 290, N 6. – P. C1651–C1659.

14. Brack A. S., Conboy M. J., Roy S. et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis // Science. – 2007. – Vol. 317, N 5839. – P. 807–810.

15. Bunnell B. A., Flaat M., Gagliardi C. et al. Adipose-derived stem cells: isolation, expansion and differentiation // Methods. – 2008. – Vol. 45, N 2. – P. 115–120.

16. Carlson M. E., Conboy I. M. Loss of stem cell regenerative capacity within aged niches // Aging Cell. – 2007. – Vol. 6, N 3. – P. 371–382.

17. Chan Y. S., Li Y., Foster W. et al. The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury // Am. J. Sports Med. – 2005. – Vol. 33, N 1. – P. 43–51.

18. Chen D., Zhao M., Mundy G. R. Bone morphogenetic proteins // Growth Factors. – 2004. – Vol. 22, N 4. – P. 233–241.

19. Chen Y., Shao J. Z., Xiang L. X. et al. Mesenchymal stem cells: a promising candidate in regenerative medicine // Int. J. Biochem. Cell Biol. – 2008. – Vol. 40, N 5. – P. 815–820.

20. Croisier J. L. Factors associated with recurrent hamstring injuries // Sports Med. – 2004. – Vol. 34, N 10. – P. 681–695.

21. Distefano G., Ferrari R. J., Weiss C. et al. Neuromuscular electrical stimulation as a method to maximize the beneficial effects of muscle stem cells transplanted into dystrophic skeletal muscle // PLoS One. – 2013. – Vol. 8, N 3. – P. e54922.

22. Ehrlich H. P. Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds // Am. J. Surg. – 2004. – Vol. 187, N 5A. – P. 29S–33S.

23. Foster W., Li Y., Usas A. et al. Gamma interferon as an antifibrosis agent in skeletal muscle // J. Orthop. Res. – 2003. – Vol. 21, N 5. – P. 798–804.

24. Frontera W. R. The Nobel Prize, stem cells, and rehabilitation // Am. J. Phys. Med. Rehabil. – 2013. – Vol. 92, N 3. – P. 189–190.

25. Grigoriou M., Tucker A. S., Sharpe P. T., Pachnis V. Expression and regulation of Lhx6 and Lhx7, a novel subfamily of LIM homeodomain encoding genes, suggests a role in mammalian head development // Development. – 1998. – Vol. 125, N 11. – P. 2063–2074.

26. Hendriks J. A., Moroni L., Riesle J. et al. The effect of scaffold-cell entrapment capacity and physico-chemical properties on cartilage regeneration // Biomaterials. – 2013. – Vol. 34, N 17. – P. 4259–4265.

27. Huard J., Li Y., Fu F. H. Muscle injuries and repair: current trends in research // J. Bone Joint Surg. Am. – 2002. – Vol. 84-A, N 5. – P. 822–832.

28. Järvinen T. A., Järvinen TL, Kääriäinen M. et al. Muscle injuries: biology and treatment // Am. J. Sports Med. – 2005. – Vol. 33, N 5. – P. 745–764.

29. Järvinen T. A., Järvinen T. L, Kääriäinen M. et al. Muscle injuries: optimising recovery // Best Pract. Res. Clin. Rheumatol. – 2007. – Vol. 21, N 2. – P. 317–331.

30. Jawad H., Lyon A. R., Harding S. E. et al. Myocardial tissue engineering // Br. Med. Bull. – 2008. – Vol. 87. – P. 31–47.

31. Kaminski A., Steinhoff G. Current status of intramyocardial bone marrow stem cell transplantation // Semin. Thorac. Cardiovasc. Surg. – 2008. – Vol. 20, N 2. – P. 119–125.

32. Kusano T., Jakob R. P., Gautier E. et al. Treatment of isolated chondral and osteochondral defects in the knee by autologous matrix-induced chondrogenesis (AMIC) // Knee Surg. Sports Traumatol. Arthrosc. – 2012. – Vol. 20, N 10. – P. 2109–2115.

33. Kwan M. D., Slater B. J., Wan D. C., Longaker M. T. Cell-based therapies for skeletal regenerative medicine // Hum. Mol. Genet. – 2008. – Vol. 17, N R1. – P. R93–R98.

34. Liu N., He S., Ma L. et al. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling // PLoS One. – 2013. – Vol. 8, N 1. – P. e54001.

35. Louro J., Pearse D. D. Stem and progenitor cell therapies: recent progress for spinal cord injury repair // Neurol. Res. – 2008. – Vol. 30, N 1. – P. 5–16.

36. Low W. C., Verfaillie C. M. (Eds.). Stem cells and regenerative medicine. – New York: World Scientific, 2008. – 551 p.

37. Lu Z. F., Zandieh Doulabi B., Wuisman P. I. et al. Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect // Biochem. Biophys. Res. Commun. – 2007. – Vol. 359, N 4. – P. 991–996.

38. Mauro A. Satellite cell of skeletal muscle fibers // J. Biophys. Biochem. Cytol. – 1961. – Vol. 9. – P. 493–495.

39. Mannarino E., Pirro M. Endothelial injury and repair: a novel theory for atherosclerosis // Angiology. – 2008. – Vol. 59, N 2 (Suppl.). – P. 69S–72S.

40. Masters J. R., Palsson B. O., Thomson J. A. (Eds.) Embryonic stem cells. – Dordrecht: Springer, 2007. – 281 p.

41. McGeary R. P., Bennett A. J., Tran Q. B. et al. Suramin: clinical uses and structure-activity relationships // Mini Rev. Med. Chem. – 2008. – Vol. 8, N 13. – P. 1384–1394.

42. McKee M. D. Recombinant human bone morphogenic protein-7: applications for clinical trauma // J. Orthop. Trauma. – 2005. – Vol. 19, N 10 (Suppl.). – P. S26–S28.

43. Mimeault M., Batra S. K. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications // Stem Cell Rev. – 2008. – Vol. 4, N 1. – P. 27–49.

44. Negishi S., Li Y., Usas A. et al. The effect of relaxin treatment on skeletal muscle injuries // Am. J. Sports Med. – 2005. – Vol. 33, N 12. – P. 1816–1824.

45. Newman M. B., Bakay R. A. Therapeutic potentials of human embryonic stem cells in Parkinson's disease // Neurotherapeutics. – 2008. – Vol. 5, N 2. – P. 237–251.

46. Nozaki M., Li Y., Zhu J. et al. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth // Am. J. Sports Med. – 2008. – Vol. 36, N 12. – P. 2354–2362.

47. Okano H. Adult neural stem cells and central nervous system repair // Ernst. Schering Res. Found Workshop. – 2006. – Vol. 60. – P. 215–228.

48. Pusic I., DiPersio J. F. The use of growth factors in hematopoietic stem cell transplantation // Curr. Pharm. Des. – 2008. – Vol. 14, N 20. – P. 1950–1961.

49. Rajasekhar V. K., Vemuri M. C. (Eds.). Regulatory Networks in Stem Cells (Stem Cell Biology and Regenerative Medicine). – Totowa: Humana Press, 2009. – 1126 p.

50. Reinecke H., Minami E., Zhu W. Z., Laflamme M. A. Cardiogenic differentiation and transdifferentiation of progenitor cells // Circ. Res. – 2008. – Vol. 103, N 10. – P. 1058–1071.

51. Seissler J., Schott M. Generation of insulin-producing beta cells from stem cells-perspectives for cell therapy in type 1 diabetes // Horm. Metab. Res. – 2008. – Vol. 40, N 2. – P. 155–161.

52. Sharma H. S., Sharma A. New therapeutic advances in CNS injury and repair // Expert. Rev. Neurother. – 2012. – Vol. 12, N 8. – P. 901–905.

53. Shen W., Li Y,, Tang Y. et al. NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis // Am. J. Pathol. – 2005. – Vol. 167, N 4. – P. 1105–1117.

54. Shen W., Prisk V., Li Y. et al. Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha // J. Appl. Physiol. – 2006. – Vol. 101, N 4. – P. 1215–1221.

55. Smith R. M. M., Sovers S. (Eds.). Stem cells medicine: the new adult stem cells regenerative therapy for cancer, spinal injuries, multiple sclerosis, Parkinson’s and other conditions. – London: Hatherligt Press, 2009. – 288 p.

56. Smith D. S. The law of regenerative medicine and tissue engineering. – CRC Press, 2012. – 270 p.

57. Stocum D. L. Regenerative biology and medicine. – London: Elsevier/AP, 2012. – 461 p.

58. Sugaya K., Merchant S. How to approach Alzheimer's disease therapy using stem cell technologies // J. Alzheimers Dis. – 2008. – Vol. 15, N 2. – P. 241–254.

59. Sullivan S., Cowan C. A., Eggan K. (Eds.). Human embryonic stem cells. – New York: Wiley Lyss & Son, 2007. – 424 p.

60. Sullivan M. J. Banking on cord blood stem cells // Nat. Rev. Cancer. – 2008. – Vol. 8, N 7. – P. 555–563.

61. Takahashi K. Bone morphogenetic protein (BMP): from basic studies to clinical approaches // Nihon Yakurigaku Zasshi. – 2000. – Vol. 116, N 4. – P. 232–240.

62. Theise N. D. Liver stem cells // Cytotechnology. – 2003. – Vol. 41, N 2/3. – P. 139–144.

63. Wataya T., Muguruma K., Sasai Y. Human pluripotent stem cell and neural differentiation // Brain Nerve. – 2008. – Vol. 60, N 10. – P. 1165–1172.

64. Weissman I. L., Shizuru J. A. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases // Blood. – 2008. – 1 Vol. 12, N 9. – P. 3543–3553.

65. Wescoe K. E., Schugar R. C., Chu C. R., Deasy B. M. The role of the biochemical and biophysical environment in chondrogenic stem cell differentiation assays and cartilage tissue engineering // Cell Biochem. Biophys. – 2008. – Vol. 52, N 2. – P. 85–102.

66. Williams K. M., Gress R. E. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation // Best Pract. Res. Clin. Haematol. – 2008. – Vol. 21, N 3. – P. 579–596.

67. Williams B. A., Keating A. Cell therapy for age-related disorders: myocardial infarction and stroke – a mini-review // Gerontology. – 2008. – Vol. 54, N 5. – P. 300–311.

68. Wu Y., Wang J., Scott P. G., Tredget E. E. Bone marrow-derived stem cells in wound healing: a review // Wound Repair. Regen. – 2007. – Vol. 15 (Suppl. 1). – P. S18–S26.

69. Yoshikawa H., Myoui A. Bone tissue engineering with porous hydroxyapatite ceramics // J. Artif. Organs. – 2005. – Vol. 8, N 3. – P. 131–136.

70. Zhu J., Li Y., Shen W. et al. Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis // J. Biol. Chem. – 2007. – Vol. 282, N 35. – P. 25852–25863.

Abstract views: 93
PDF Downloads: 31
Published
2017-03-30
How to Cite
Zalessky, V. N. (2017). Stem cells, regenerative medicine and cellular rehabilitation. Likars’ka Sprava, (1-2), 20-30. Retrieved from https://liksprava.com/index.php/journal/article/view/4
Section
Regenerative medicine